Share on StockTwits

Achaogen (NASDAQ:AKAO) announced its earnings results on Tuesday. The company reported ($0.20) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.19) by $0.01, Analyst Ratings Network reports.

Shares of Achaogen (NASDAQ:AKAO) opened at 10.14 on Tuesday. Achaogen has a 1-year low of $9.01 and a 1-year high of $19.69. The stock’s 50-day moving average is $12.08 and its 200-day moving average is $13.75. The company’s market cap is $179.3 million.

On a related note, analysts at Gabelli initiated coverage on shares of Achaogen in a research note on Friday, June 20th. They set a “hold” rating on the stock. One analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $22.50.

Achaogen, Inc is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of antibacterials to treat multi-drug resistant (NASDAQ:AKAO), gram-negative infections.

Receive News & Ratings for Achaogen Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Achaogen Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.